Calidi Biotherapeutics, Inc. Quarterly Current Ratio in % from Q2 2022 to Q4 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Calidi Biotherapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q4 2024.
  • Calidi Biotherapeutics, Inc. Current Ratio for the quarter ending December 31, 2024 was 32.6 %, a 31.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2024 32.6 -14.9 -31.3% Dec 31, 2024
Q3 2024 20.2 +0.53 +2.69% Sep 30, 2024
Q2 2024 39.8 +35.9 +910% Jun 30, 2024
Q1 2024 42.3 +37.9 +847% Mar 31, 2024
Q4 2023 47.5 +40.7 +601% Dec 31, 2023
Q3 2023 19.7 -130 -86.8% Sep 30, 2023
Q2 2023 3.94 -429 -99.1% Jun 30, 2023
Q1 2023 4.47 Mar 31, 2023
Q4 2022 6.78 Dec 31, 2022
Q3 2022 150 Sep 30, 2022
Q2 2022 433 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.